Present an integrated clinical program for RTX-240 and oncology pipeline
Not delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 11 Jan 2021
- Due
- 31 Dec 2021
- Checked
- 25 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Present an integrated clinical program for RTX-240, including plans for expansion cohorts, and oncology pipeline”
What we found
Evidence strength A What the grades mean
The company explicitly stated in a 2022 filing that it planned to report the integrated clinical development plan for RTX-240 during the first quarter of 2022, which is after the 2021 deadline.
-
A Rubius Therapeutics, Inc. 10-K filed 2022-02-25
“We plan to report updated clinical results for this trial, along with an integrated clinical development plan that includes Phase 2 expansion cohorts during the first quarter of 2022.” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Present
- Deliverable
- Integrated clinical program presentation
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
- Third check on a negative finding: agreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Rubius Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C709401-021469 · Corrections policy